Health Trials

Lupus Landmark Study: A Prospective Registry and Biorepository

ConditionsSystemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorLupus Research Alliance

About this trial

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Eligibility criteria

Qualifiers

Able to understand and comply with study procedures and voluntarily sign a written informed consent document

Age 18 years or older at the time of enrollment

Disqualifiers

Not able to obtain consent

Not able to meet protocol visit requirements

Pregnant at the time of enrollment

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,500 Participants
are grouped into 4 trial groups

Sponsors and collaborators

Lupus Research Alliance

Lead sponsor

Source ClinicalTrials.gov